•
Dec 31, 2013

Jazz Pharmaceuticals Q4 2013 Earnings Report

Total Revenue
$236M
Previous year: $184M
+28.4%
EPS
$1.72
Previous year: $1.53
+12.4%
Gross Profit
$210M
Previous year: $158M
+33.0%
Cash and Equivalents
$637M
Previous year: $387M
+64.4%
Total Assets
$2.24B
Previous year: $1.97B
+13.8%

Jazz Pharmaceuticals

Jazz Pharmaceuticals